WELLINGTON MANAGEMENT GROUP LLP

Position in VERA — Vera Therapeutics, Inc.

CIK 902219 Boston, MA

Position in VERA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,408,004

+$1,332,767 QoQ

Shares Held

59,856

+181.9% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 96.76222935044106.ToString("F0")% None 3.2377706495589416.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. VERA ranks #101 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,408,004	59,856	+181.9%	Shares	Defined	2026-05-15
2025-12-31	$1,075,237	21,233	-6.6%	Shares	Defined	2026-02-17
2025-09-30	$660,793	22,739	+22.8%	Shares	Defined	2025-11-14
2025-06-30	$436,141	18,512	-2.9%	Shares	Defined	2025-08-14
2025-03-31	$457,843	19,061	+5.8%	Shares	Defined	2025-05-13
2024-12-31	$761,979	18,018	-10.2%	Shares	Defined	2025-02-12
2024-09-30	$887,136	20,071	-82.2%	Shares	Defined	2024-11-14
2024-06-30	$4,075,278	112,639	-13.9%	Shares	Defined	2024-08-14
2024-03-31	$5,639,836	130,794	+54.8%	Shares	Defined	2024-05-15
2023-09-30	$1,158,576	84,506	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.